PSEN2 p.Pro69Ala
c.205C>G · rs202133351 · VCV191771
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0593 | likely benign |
|---|---|---|
| REVEL | 0.432 | indeterminate |
| SaProt | LLR -6.68 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.3 | GERP 0.34, phastCons 0.98 |
| Regional constraint | o/e 0.89 | unconstrained · MANE · 14 kb · p 0.0074 · regional, not allelic |
| Overall | ||
| CADD | 12.81 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.0141% | 7,112 |
| Remaining individualsnot grpmax-eligible | 0.008% | 12,497 |
| European (non-Finnish)grpmax | 0.00686% | 14,568 |
| African / African-American | 0.00134% | 74,894 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PSEN2
- Protein
- p.Pro69Ala
- Coding
- c.205C>G
- MANE Select
- NM_000447
- dbSNP
- rs202133351
- Type
- single nucleotide variant
- Location
- chr1:226883768 (GRCh38)
- Gene constraint
- LOEUF 0.85 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 71.99 · 2 PDB
- Residue 69
- the 'disordered' region
Disease context
Alzheimer disease 4 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: dilated cardiomyopathy 1V
For Early-onset autosomal dominant Alzheimer disease (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Adult
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- PSEN2 p.Pro69= Likely benign ★★ same residue
- PSEN2 p.Asn141Ile Pathogenic ★★ same condition
- PSEN2 p.Thr122Pro Pathogenic/Likely pathogenic ★★ same condition
- PSEN2 c.*20G>A Uncertain significance ★★ same condition
- PSEN2 p.Ala258Thr Uncertain significance ★★ ⚠ same condition
- PSEN2 p.Ala291Val Uncertain significance ★★ ⚠ same condition
- PSEN2 p.Arg110Cys Uncertain significance ★★ ⚠ same condition
- PSEN2 p.Arg29Cys Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/psen2-p-pro69ala (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown